title: Gemcitabine (Gemzar) and radiotherapy--is it feasible?
authors.affiliation: Third Medical Department, University Hospital Grosshadern, Munich, Germany. ralf.wilkowski@radonc.med.uni-muenchen.de
authors.forename: R
authors.initials: R
authors.lastname: Wilkowski
authors.forename: V
authors.initials: V
authors.lastname: Heinemann
authors.forename: C
authors.initials: C
authors.lastname: Stoffregen
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D006801:Humans; D010190:Pancreatic Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D012189:Retrospective Studies; D000093542:Gemcitabine
chemical_list: D003841:Deoxycytidine; D002945:Cisplatin; D000093542:Gemcitabine